ArticleInternational journal of general medicine2021

Development of a Prognostic Nomogram for Patients with Lung Adenocarcinoma in the Stages I, II, and III Based on Immune Scores.

Hui Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.